Related Experiment Video
Updated: May 5, 2026

11:21
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.2K
Scalable Approach to Consumer Wearable Postmarket Surveillance: Development and Validation Study
Richard M Yoo1, Ben T Viggiano1, Krishna N Pundi2
1Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States.
JMIR Medical Informatics
|April 10, 2024
Summary
Consumer wearables can provide atrial fibrillation (AF) prediagnoses. This study developed an effective electronic health record (EHR) surveillance system to track these prediagnoses and found they correlate with increased anticoagulant use and AF diagnosis.
Area of Science:
- Medical Informatics
- Cardiology
- Digital Health
Background:
- Consumer wearables offer prediagnoses, potentially impacting healthcare.
- Electronic health record (EHR) systems lack standardized terms for wearable data, hindering postmarket surveillance.
- Atrial fibrillation (AF) prediagnoses from wearables are a key area of interest.
Purpose of the Study:
- To develop and validate an EHR-based surveillance system for consumer wearable AF prediagnoses.
- To demonstrate the feasibility and efficacy of using weak supervision for EHR data labeling.
- To compare patient characteristics and care patterns following wearable-detected AF prediagnoses.
Main Methods:
- Applied data programming and the Snorkel framework to create labeling functions for AF prediagnoses.
- Developed a labeler model to probabilistically label clinical notes for AF prediagnoses.
- Fine-tuned a Clinical-Longformer classifier on labeled notes to identify patients with AF prediagnoses.
- Conducted a retrospective cohort study comparing patients with and without AF prediagnoses.
Main Results:
- The labeler model achieved high accuracy (0.92) and F1-score (0.77).
- The Clinical-Longformer classifier accurately identified AF prediagnoses (0.95 accuracy, 0.83 F1-score).
- Patients with AF prediagnoses were older, male, White, and had higher CHA2DS2-VASc scores.
- Prediagnoses correlated with increased anticoagulant use (e.g., apixaban, rivaroxaban) and eventual AF diagnosis.
Conclusions:
- An EHR-based surveillance system for wearable AF prediagnoses is feasible and effective.
- The system can identify patient cohorts for further study and verify findings from large trials.
- Further research is needed to generalize findings across diverse patient populations and healthcare settings.
Keywords:
EHRNLParrhythmiaartificial intelligenceatrial fibrillationcardiologyclassifierconsumerconsumer wearable devicesconsumersdevicedevicesdiagnosediagnosiselectronic health recordelectronic health recordsevaluationheartlabelerlabelingmachine learningmonitoringnatural language processingpostmarket surveillancesurveillancewearablewearables
